C075-0152 Screening compound: 2-{[3-(4-methoxyphenyl)-4-oxo-3,4-dihydrophthalazin-1-yl]formamido}-N-(pyridin-2-yl)acetamide

C075-0152 Screening compound: 2-{[3-(4-methoxyphenyl)-4-oxo-3,4-dihydrophthalazin-1-yl]formamido}-N-(pyridin-2-yl)acetamide
C075-0152 Screening compound: 2-{[3-(4-methoxyphenyl)-4-oxo-3,4-dihydrophthalazin-1-yl]formamido}-N-(pyridin-2-yl)acetamide alternative view

Chemical Structure Depiction of ChemDiv screening compound C075-0152
2-{[3-(4-methoxyphenyl)-4-oxo-3,4-dihydrophthalazin-1-yl]formamido}-N-(pyridin-2-yl)acetamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

C075-0152

Molecular Formula

C23H19N5O4 (C23 H19 N5 O4)

Compound Name

2-{[3-(4-methoxyphenyl)-4-oxo-3,4-dihydrophthalazin-1-yl]formamido}-N-(pyridin-2-yl)acetamide

IUPAC name

2-{[3-(4-methoxyphenyl)-4-oxo-34-dihydrophthalazin-1-yl]formamido}-N-(pyridin-2-yl)acetamide

SMILES

COc(cc1)ccc1N1N=C(C(NCC(Nc2ncccc2)=O)=O)c(cccc2)c2C1=O

InChI

InChI=1S/C23H19N5O4/c1-32-16-11-9-15(10-12-16)28-23(31)18-7-3-2-6-17(18)21(27-28)22(30)25-14-20(29)26-19-8-4-5-13-24-19/h2-13H,14H2,1H3,(H,25,30)(H,24,26,29)

InChI Key

RSRDJVIBWQOJDL-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD14717714

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

429.44

Hydrogen Bond Acceptors Count

9.00

Hydrogen Bond Donors Count

2.00

Rotatable Bond Count

8.00

Number of Nitrogen and Oxygen Atoms

9

Partition Coefficient, logP

2.604

Distribution Coefficient, logD

2.604

Water Solubility, LogSw

-3.42

Polar Surface Area

90.769

Acid Dissociation Constant (pKa)

11.18

Base Dissociation Constant (pKb)

2.25

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

8.70

C075-0152 in Drug Discovery

Included in Screening Libraries

Chelators targeting matrix metalloproteinases library (8930 compounds)

Dark Chemical Matter Library (18430 compounds)

Protein Kinases Inhibitors Library (36801 compounds)

ChemoGenomic Annotated Library for Phenotypic Screening (89798 compounds)

Protein Tyrosine Phosphatase Non-receptor Type (PTPN) Targeted Library (32556 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Digestive system
  • Cardiovascular
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
  • Nervous system
  • Hemic and lymphatic
  • Cardiovascular
  • Cancer
  • Nervous system
  • Male
  • Female
  • Hemic and lymphatic
  • Skin
  • Endocrine
Targets:
  • Proteases
  • Kinases
  • Phosphatases
Structure:
  • Pool

References: we are preparing a list of scientific research reports with C075-0152 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound C075-0152?
Check Price and Availability of C075-0152, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of C075-0152 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for C075-0152
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for C075-0152
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of C075-0152 available by request